Answers are grounded in this paper and cite their sources.
Background: Pseudomyxoma peritonei (PMP) is a very rare, indolent cancer characterized by the accumulation of mucinous ascites in the peritoneal cavity and is commonly caused by a low-grade appendiceal mucinous neoplasm. Case: We report a case of a 66-year-old man who presented with a 4–5-month history of progressive abdominal distension and abdominal pain. Investigations showed a cystic lesion associated with the appendix on computed tomography (CT) scan, hemorrhagic, gelatinous (jelly-like) ascites on drainage, significantly elevated tumor markers (carcinoembryonic antigen and cancer antigen 19-9), and hypermetabolic peritoneal and omental thickening without distant metastases or an isolated fluorodeoxyglucose (FDG)-avid focal mass on FDG-positron emission tomography/computed tomography. Colonoscopy findings were normal, and ascitic fluid cytology was negative for malignancy. Peritoneal biopsy during diagnostic laparoscopy showed high-grade mucinous carcinoma peritonei [Peritoneal Surface Oncology Group International (PSOGI) classification], of presumed appendiceal origin. The patient was subsequently lost to follow-up. Discussion: The present case demonstrates that negative ascitic cytology does not exclude PMP and that histopathological examination of a peritoneal biopsy is essential when clinical and radiological suspicion remains high. Conclusion: Negative ascitic cytology does not exclude PMP. In progressive mucinous ascites with typical imaging and tumor-marker findings, early peritoneal biopsy and multidisciplinary referral are advised. However, because the patient was lost to follow-up, no conclusions can be drawn regarding treatment response or survival.
No takes yet. Share an insight, caveat, or question.
Kipkoech et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: